# STT3A

## Overview
The STT3A gene encodes a catalytic subunit of the oligosaccharyltransferase (OST) complex, which is integral to the process of N-linked glycosylation in eukaryotic cells. This gene is responsible for the production of the STT3 oligosaccharyltransferase complex catalytic subunit A, a transmembrane protein located in the endoplasmic reticulum. The protein plays a pivotal role in the co-translational glycosylation of nascent polypeptides, ensuring the proper addition of oligosaccharides to asparagine residues, which is crucial for protein folding and stability (Wilson2021Active; RuizCanada2009Cotranslational). The STT3A protein is characterized by specific motifs and conserved regions that are essential for its enzymatic activity, and it interacts with other components of the OST complex to facilitate glycosylation (Mohanty2020Structural; Niu2020Comparative). Mutations in the STT3A gene are linked to congenital disorders of glycosylation, highlighting its significance in human health and disease (Wilson2021Active).

## Structure
The STT3A protein is a catalytic subunit of the oligosaccharyltransferase (OST) complex, essential for N-linked glycosylation. It is embedded in the endoplasmic reticulum membrane and features multiple transmembrane domains. The protein's structure includes conserved regions crucial for its enzymatic activity, particularly at the catalytic site where variants can significantly impact function (Wilson2021Active). 

The STT3A protein contains specific motifs, such as the WWDYG and DXXK motifs, which form the active center necessary for its catalytic function (Niu2020Comparative). These motifs are involved in the transfer of oligosaccharides to nascent polypeptides, a critical step in protein glycosylation. The catalytic mechanism involves residues like D49 and E351, which facilitate the activation of the amide nitrogen of the acceptor asparagine through hydrogen bonding (Mohanty2020Structural).

STT3A is part of the OST-A complex, which includes interactions with other subunits such as DC2, contributing to its role in co-translational glycosylation (Mohanty2020Structural). The protein's structure and function are highly conserved across eukaryotes, underscoring its importance in cellular processes (Wilson2021Active).

## Function
The STT3A gene encodes a catalytic subunit of the oligosaccharyltransferase (OST) complex, which is essential for N-linked glycosylation in the endoplasmic reticulum (ER) of eukaryotic cells. This process involves the transfer of oligosaccharides to nascent polypeptides, a critical step for proper protein folding, stability, and function (Wilson2021Active; RuizCanada2009Cotranslational). STT3A is primarily responsible for cotranslational glycosylation, occurring as proteins are synthesized and translocated into the ER. It ensures that glycans are correctly added to polypeptides, which is crucial for the ER quality control pathways (Cherepanova2019Quantitative; RuizCanada2009Cotranslational).

The STT3A complex is associated with the protein translocation channel, allowing it to efficiently glycosylate nascent proteins, particularly those with suboptimal acceptor sites or in cysteine-rich domains (Cherepanova2019Quantitative). This activity is vital for the proper folding and function of glycoproteins, including secretory and membrane proteins (Cherepanova2019Quantitative). The STT3A complex also plays a role in maintaining protein homeostasis and activating the unfolded protein response (UPR) pathway when glycosylation is disrupted (Cherepanova2016Mammalian). Its function is distinct from the STT3B complex, which performs posttranslational glycosylation of sites missed by STT3A (Wilson2021Active).

## Clinical Significance
Mutations in the STT3A gene are associated with congenital disorders of glycosylation (CDG), specifically a dominant type I CDG characterized by neuromusculoskeletal findings. These disorders result from heterozygous missense variants in STT3A, affecting the catalytic site of the oligosaccharyltransferase (OST) complex, which is crucial for N-glycosylation. Affected individuals often present with skeletal anomalies, short stature, macrocephaly, dysmorphic features, and intellectual disability. Additional symptoms can include increased muscle tone and muscle cramps (Wilson2021Active).

The dominant form of STT3A-CDG is caused by de novo and autosomal dominantly inherited variants, leading to a dominant negative effect on N-glycosylation, resulting in underglycosylated proteins (Wilson2021Active). In contrast, the recessive form of STT3A-CDG is associated with more severe symptoms, such as failure to thrive, microcephaly, developmental delay, and seizures (Wilson2021Active).

STT3A mutations can also lead to specific coagulation defects, such as deficiencies in Factor VIII and von Willebrand factor, due to impaired secretion and function of these glycoproteins (Chang2019Factor). These findings highlight the critical role of STT3A in glycosylation and its impact on various physiological processes.

## Interactions
STT3A is a catalytic subunit of the oligosaccharyltransferase (OST) complex, which plays a crucial role in N-linked glycosylation. It interacts directly with the protein translocation channel, known as the Sec61 complex, to mediate cotranslational glycosylation of nascent polypeptides as they enter the lumen of the endoplasmic reticulum (ER) (Cherepanova2019Quantitative). This interaction is essential for the transfer of oligosaccharides onto asparagine residues in acceptor sites of nascent proteins.

STT3A is part of the OST-A complex, which is involved in cotranslational N-glycosylation, working closely with the translocon to transfer oligosaccharides to nascent polypeptides (Lu2018Mammalian). The STT3A complex is less tolerant of intermediate lipid-linked oligosaccharides (LLOs) compared to its counterpart, STT3B, and does not significantly hydrolyze LLOs (Lu2018Mammalian).

In the context of nasopharyngeal carcinoma, STT3A interacts with the c-Jun protein as part of a pathway regulated by TGF-b1, which promotes PD-L1 glycosylation, contributing to immune escape (Ma2022TGFβ1Mediated). This interaction highlights the regulatory role of STT3A in post-translational modifications that are critical for tumor immunosuppressive functions.


## References


[1. (Chang2019Factor) Irene J. Chang, Heather M. Byers, Bobby G. Ng, John Lawrence Merritt, Reid Gilmore, Shiteshu Shrimal, Wei Wei, Yuan Zhang, Amanda B. Blair, Hudson H. Freeze, Bin Zhang, and Christina Lam. Factor viii and vwf deficiency in stt3a‐cdg. Journal of Inherited Metabolic Disease, 42(2):325–332, January 2019. URL: http://dx.doi.org/10.1002/jimd.12021, doi:10.1002/jimd.12021. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jimd.12021)

[2. (Niu2020Comparative) Guanting Niu, Zhuqing Shao, Chuanfa Liu, Tianshu Chen, Qingsong Jiao, and Zhi Hong. Comparative and evolutionary analyses of the divergence of plant oligosaccharyltransferase stt3 isoforms. FEBS Open Bio, 10(3):468–483, February 2020. URL: http://dx.doi.org/10.1002/2211-5463.12804, doi:10.1002/2211-5463.12804. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/2211-5463.12804)

[3. (Lu2018Mammalian) Hua Lu, Charles S. Fermaintt, Natalia A. Cherepanova, Reid Gilmore, Nan Yan, and Mark A. Lehrman. Mammalian stt3a/b oligosaccharyltransferases segregate n-glycosylation at the translocon from lipid-linked oligosaccharide hydrolysis. Proceedings of the National Academy of Sciences, 115(38):9557–9562, September 2018. URL: http://dx.doi.org/10.1073/pnas.1806034115, doi:10.1073/pnas.1806034115. This article has 26 citations.](https://doi.org/10.1073/pnas.1806034115)

[4. (Ma2022TGFβ1Mediated) Xue-Min Ma, Yun-Fan Luo, Fang-Fang Zeng, Chang Su, Xiong Liu, Xiang-Ping Li, and Juan Lu. Tgf-β1-mediated pd-l1 glycosylation contributes to immune escape via c-jun/stt3a pathway in nasopharyngeal carcinoma. Frontiers in Oncology, March 2022. URL: http://dx.doi.org/10.3389/fonc.2022.815437, doi:10.3389/fonc.2022.815437. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2022.815437)

[5. (Cherepanova2019Quantitative) Natalia A. Cherepanova, Sergey V. Venev, John D. Leszyk, Scott A. Shaffer, and Reid Gilmore. Quantitative glycoproteomics reveals new classes of stt3a- and stt3b-dependent n-glycosylation sites. Journal of Cell Biology, 218(8):2782–2796, July 2019. URL: http://dx.doi.org/10.1083/jcb.201904004, doi:10.1083/jcb.201904004. This article has 50 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1083/jcb.201904004)

[6. (Cherepanova2016Mammalian) Natalia A. Cherepanova and Reid Gilmore. Mammalian cells lacking either the cotranslational or posttranslocational oligosaccharyltransferase complex display substrate-dependent defects in asparagine linked glycosylation. Scientific Reports, February 2016. URL: http://dx.doi.org/10.1038/srep20946, doi:10.1038/srep20946. This article has 83 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/srep20946)

[7. (Mohanty2020Structural) Smita Mohanty, Bharat P Chaudhary, and David Zoetewey. Structural insight into the mechanism of n-linked glycosylation by oligosaccharyltransferase. Biomolecules, 10(4):624, April 2020. URL: http://dx.doi.org/10.3390/biom10040624, doi:10.3390/biom10040624. This article has 41 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/biom10040624)

[8. (Wilson2021Active) Matthew P. Wilson, Alejandro Garanto, Filippo Pinto e Vairo, Bobby G. Ng, Wasantha K. Ranatunga, Marina Ventouratou, Melissa Baerenfaenger, Karin Huijben, Christian Thiel, Angel Ashikov, Liesbeth Keldermans, Erika Souche, Sandrine Vuillaumier-Barrot, Thierry Dupré, Helen Michelakakis, Agata Fiumara, James Pitt, Susan M. White, Sze Chern Lim, Lyndon Gallacher, Heidi Peters, Daisy Rymen, Peter Witters, Antonia Ribes, Blai Morales-Romero, Agustí Rodríguez-Palmero, Diana Ballhausen, Pascale de Lonlay, Rita Barone, Mirian C.H. Janssen, Jaak Jaeken, Hudson H. Freeze, Gert Matthijs, Eva Morava, and Dirk J. Lefeber. Active site variants in stt3a cause a dominant type i congenital disorder of glycosylation with neuromusculoskeletal findings. The American Journal of Human Genetics, 108(11):2130–2144, November 2021. URL: http://dx.doi.org/10.1016/j.ajhg.2021.09.012, doi:10.1016/j.ajhg.2021.09.012. This article has 6 citations.](https://doi.org/10.1016/j.ajhg.2021.09.012)

[9. (RuizCanada2009Cotranslational) Catalina Ruiz-Canada, Daniel J. Kelleher, and Reid Gilmore. Cotranslational and posttranslational n-glycosylation of polypeptides by distinct mammalian ost isoforms. Cell, 136(2):272–283, January 2009. URL: http://dx.doi.org/10.1016/j.cell.2008.11.047, doi:10.1016/j.cell.2008.11.047. This article has 311 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.cell.2008.11.047)